Moderna seeks US approval of second Covid booster
The request comes days after Pfizer-BioNTech, makers of the other Covid mRNA vaccine, also requested emergency approval for a second booster shot, but their request was limited to adults aged 65 and older.
Pfizer-BioNTech Covid jab less effective in ages 5-11, US study shows
However, a paediatric infectious disease expert says it's not surprising that protection against mild illness would wane and that the goal of the vaccine is to protect against severe illness.
BioNTech produces 10 times more antibodies than China’s Sinovac, study shows
But researchers say people should still get vaccinated with Sinovac if there is no other option because some protection is always better than none.
Anti-vaxers ran with vaccine trial participant’s mystery foot sores
Doctors could not explain the cause of Patricia’s problem but anti-vaccination groups went viral with it.